<- Go Home
Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Market Cap
$697.6M
Volume
412.4K
Cash and Equivalents
$210.0M
EBITDA
$96.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$712.6M
Profit Margin
64.33%
52 Week High
$21.48
52 Week Low
$9.93
Dividend
5.00%
Price / Book Value
-0.91
Price / Earnings
12.12
Price / Tangible Book Value
-0.88
Enterprise Value
$2.1B
Enterprise Value / EBITDA
19.95
Operating Income
$59.2M
Return on Equity
7.45%
Return on Assets
3.13
Cash and Short Term Investments
$210.0M
Debt
$1.6B
Equity
-$768.8M
Revenue
$1.1B
Unlevered FCF
$33.0M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium